Markets:

Overview

News

Currencies

International

Treasuries

Petros Pharmaceuticals, Inc. - Common Stock (NQ:PTPI)

0.0664 UNCHANGED

Last Price Updated: 4:00 PM EDT, May 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Petros Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 20, 2023

Gainers Aditxt, Inc. (NASDAQ: ADTX) shares gained 68.6% to $1.45. Aditxt signed asset purchase agreement to acquire 50% ownership of Global Response Aid with rights to manufacture and market...

Via Benzinga

Dow Tumbles 150 Points; Tesla Shares Drop After Q1 Results ↗

April 20, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping over 150 points on Thursday. Following the market opening Thursday, the Dow traded down 0.50% to 33,727.89 while the NASDAQ fell 0.49%...

Via Benzinga

Petros Pharmaceuticals Announces Reverse Stock Split

November 30, 2022

Via ACCESSWIRE

Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 18, 2023

Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional...

Via Benzinga

US Stocks Mixed; Housing Starts Edge Lower In March ↗

April 18, 2023

U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping over 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.12% to 33,945.01 while the NASDAQ rose...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 18, 2023

Via Benzinga

Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 17, 2023

Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 17, 2023

Via Benzinga

Why Marpai Shares Are Trading Lower By 26%; Here Are 20 Stocks Moving Premarket ↗

April 17, 2023

Gainers CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) jumped 153% to $5.96 in pre-market trading after jumping 243% on Friday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

April 17, 2023

We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 14, 2023

Via Benzinga

Why Is Mind Medicine (MNMD) Stock Up 26% Today? ↗

April 14, 2023

Mind Medicine (MNMD) stock is on the rise Friday after releasing positive results from a Phase 2 clinical trial of lysergide (LSD).

Via InvestorPlace

Why Is National CineMedia (NCMI) Stock Down 12% Today? ↗

April 14, 2023

National CineMedia (NCMI) stock is on the move Friday as the movie theater ad company's shares continue to see wild swings this week.

Via InvestorPlace

Why Teva Pharmaceutical Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 14, 2023

Gainers SAI.TECH Global Corporation (NASDAQ: SAI) jumped 269% to $5.61 after gaining around 25% on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 14, 2023

Via Benzinga

Why Is Pear Therapeutics (PEAR) Stock Down 26% Today? ↗

April 14, 2023

Pear Therapeutics (PEAR) stock is falling on Friday after the company's recent bankruptcy filing continues to weigh on its shares.

Via InvestorPlace

Why Is Petros Pharmaceuticals (PTPI) Stock Up 101% Today? ↗

April 14, 2023

Petros Pharmaceuticals (PTPI) stock is rocketing higher on Friday despite a lack of news from the men's health pharmaceutical company.

Via InvestorPlace

Why Navidea Biopharmaceuticals Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket ↗

April 14, 2023

Gainers CXApp Inc. (NASDAQ: CXAI) jumped 318% to $29.80 in pre-market trading after gaining more than 345% on Thursday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

April 14, 2023

It's time for another dive into the biggest pre-market stock movers with all the latest news traders need to know about for Friday!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 04, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 14, 2023

Tuesday's morning session saw 84 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

March 06, 2023

On Monday, 36 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

December 08, 2022

During Thursday's trading, 138 companies set new 52-week lows.

Via Benzinga

Petros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Corporate Update

November 15, 2022

Via ACCESSWIRE

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

October 28, 2022

Pre-market stock movers continue to be a major topic as we dive into the latest news investors need to know about on Friday!

Via InvestorPlace

Why Pinterest Shares Are Trading Higher; Here Are 27 Stocks Moving Premarket ↗

October 28, 2022

Gainers Zovio Inc (NASDAQ: ZVO) rose 39.5% to $0.2449 in pre-market trading after gaining 7% on Thursday.

Via Benzinga

Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday ↗

October 26, 2022

Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company.

Via Benzinga

Why Crown Holdings Shares Are Trading Lower By Around 22%? Here Are 46 Stocks Moving In Tuesday's Mid-Day Session ↗

October 25, 2022

Gainers

Via Benzinga

New FDA-Approved Labeling for Petros Pharmaceuticals’ STENDRA (avanafil) Now Includes Efficacy Data Regarding Use in Men Who Have Undergone Radical Prostatectomy

October 25, 2022

Via ACCESSWIRE

Petros Pharmaceuticals to Participate in Two October 2022 Conferences

October 21, 2022

Via ACCESSWIRE

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.